Gene · 3108
Papers2,126
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,126
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Understanding medication safety involving patient transfer from intensive care to hospital ward: a qualitative sociotechnical factor study. | BMJ Open | 2023 | 37130684 | PubTator, text mining | PubMed |
| Applying causal discovery to single-cell analyses using CausalCell. | Elife | 2023 | 37129360 | PubTator, text mining | PubMed |
| The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer. | Nat Cancer | 2023 | 37127787 | PubTator, text mining | PubMed |
| Human leukocyte antigen and tumor immunotherapy (Review). | Int J Oncol | 2023 | 37114561 | PubTator, text mining | PubMed |
| Amino acid polymorphisms in human histocompatibility leukocyte antigen class II and proinsulin epitope have impacts on type 1 diabetes mellitus induced by immune-checkpoint inhibitors. | Front Immunol | 2023 | 37114039 | PubTator, text mining | PubMed |
| The natural history of QTc interval and its clinical impact in coronavirus disease 2019 survivors after 1 year. | Front Cardiovasc Med | 2023 | 37089886 | PubTator, text mining | PubMed |
| Glutathione peroxidase 3 is a novel clinical diagnostic biomarker and potential therapeutic target for neutrophils in rheumatoid arthritis. | Arthritis Res Ther | 2023 | 37087463 | PubTator, text mining | PubMed |
| Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer. | Oncogenesis | 2023 | 37080999 | PubTator, text mining | PubMed |
| Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils. | J Immunother Cancer | 2023 | 37072349 | PubTator, text mining | PubMed |
| Pan-cancer landscape of CENPO and its underlying mechanism in LUAD. | Respir Res | 2023 | 37061713 | PubTator, text mining | PubMed |
| A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design. | J Exp Med | 2023 | 37058141 | PubTator, text mining | PubMed |
| Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors. | Clin Cancer Res | 2023 | 37053197 | PubTator, text mining | PubMed |
| Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases-Focus on the Major Histocompatibility Complex (MHC) Antigen Processing Pathway. | Int J Mol Sci | 2023 | 37047709 | PubTator, text mining | PubMed |
| A Machine Learning Model to Predict Survival and Therapeutic Responses in Multiple Myeloma. | Int J Mol Sci | 2023 | 37047654 | PubTator, text mining | PubMed |
| m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy. | Sci Rep | 2023 | 37041267 | PubTator, text mining | PubMed |
| PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial. | Nat Cancer | 2023 | 37038006 | PubTator, text mining | PubMed |
| An immune-related gene signature predicts the 28-day mortality in patients with sepsis. | Front Immunol | 2023 | 37033939 | PubTator, text mining | PubMed |
| Metabolic dysregulation impairs lymphocyte function during severe SARS-CoV-2 infection. | Commun Biol | 2023 | 37029220 | PubTator, text mining | PubMed |
| Integrative single-cell sequencing analysis distinguishes survival-associated cells from the breast cancer microenvironment. | Cancer Med | 2023 | 37021816 | PubTator, text mining | PubMed |
| BET Inhibition Sensitizes Immunologically Cold Rb-Deficient Prostate Cancer to Immune Checkpoint Blockade. | Mol Cancer Ther | 2023 | 37014264 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3108/papers?page=11